By Amy Norton HealthDay Reporter THURSDAY, Aug. 12, 2021 (HealthDay News) — Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests. Researchers in South Korea found that among older people who’d been having memory issues, those using diabetes drugs called DDP-4 inhibitors… Continue reading Some Diabetes Meds Might Also Lower Alzheimer's Risk
By Robert PreidtHealthDay Reporter MONDAY, Aug. 2, 2021 (HealthDay News) — Could a drug used to treat amyotrophic lateral sclerosis (ALS) help people with mild Alzheimer’s disease? The results of a small new study suggest the strategy could work. Riluzole has been used for more than 20 years to slow the progression of ALS, commonly… Continue reading An ALS Drug Shows Early Promise Against Alzheimer's
By Robin FosterHealthDay Reporter TUESDAY, July 13, 2021 (Healthday News) — Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer’s drug whose high price tag and unproven benefits have prompted widespread controversy. Medicare’s announcement came the same day that leaders of two House committees… Continue reading Medicare Mulls Coverage for New Alzheimer's Drug
July 7, 2021 — Rolfe Johnson is a glass-half-full kind of guy, but also a realist. As a longtime attorney in Houston, only recently retired, he specialized in taking companies public, so he is also a man who knows how to do his homework.
Johnson also has Alzheimer’s disease. So, when his neurologist… Continue reading Controversial New Alzheimer's Drug: Why Some Patients Say Yes
Advocates Who Backed Approval Decry Cost
Aducanumab had a rocky road to approval but had unwavering backing from the Alzheimer’s Association and at least one other organization, UsAgainstAlzheimer’s.
The Alzheimer’s Association was particularly outspoken in its support, and, as reported by Medscape in March, was accused of potential conflict of interest by… Continue reading Group Wants FDA Leaders Ousted Over Alzheimer's Drug Approval
June 9, 2021 — The FDA’s approval on Monday of a new drug to treat Alzheimer’s disease was met with both praise and criticism. As the first Alzheimer’s drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price… Continue reading Controversial New Alzheimer's Drug: What to Know
In March 2019, late-stage international trials of aducanumab, involving about 3,000 patients, were halted when analysis showed the drug, given as a monthly infusion, was not better at slowing the deterioration of memory and thinking problems than a dummy drug. Source link
March 15, 2021 — An experimental drug appeared to slow cognitive decline in people with early Alzheimer’s disease, according to newly published research. The drug, donanemab, is an antibody that targets and removes plaques from the brain called amyloid-beta, which are thought to play a role in Alzheimer’s disease. Compared to people in the study… Continue reading New Alzheimer's Drug Slows Cognitive Decline in Early Test
By Dennis Thompson HealthDay Reporter WEDNESDAY, March 10, 2021 (HealthDay News) — Many older adults with dementia are prescribed dangerous combinations of drugs that raise their risk of overdose, falls and further mental deterioration, a new study finds. About 1 in 7 people with dementia living outside of nursing homes are taking three or more… Continue reading Alzheimer's Patients Often Given Too Many Meds
By Robert Preidt
TUESDAY, Feb. 9, 2021 (HealthDay News) — Older men whose blood pressure rises at night may be at increased risk for Alzheimer’s disease, a new study suggests.
Blood pressure changes over 24 hours. It typically goes up during the day and dips at nighttime. But some people have an… Continue reading High BP at Night, Alzheimer's Risk May Rise, Too